DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 74 filers reported holding DERMA SCIENCES INC in Q2 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $431,000 | -65.2% | 109,327 | -72.7% | 0.00% | -66.7% |
Q1 2016 | $1,240,000 | -32.2% | 400,000 | 0.0% | 0.00% | -40.0% |
Q4 2015 | $1,828,000 | -3.0% | 400,000 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $1,884,000 | -34.2% | 400,000 | 0.0% | 0.01% | -28.6% |
Q2 2015 | $2,864,000 | +23.0% | 400,000 | +45.5% | 0.01% | +16.7% |
Q1 2015 | $2,329,000 | +6.7% | 275,000 | +17.3% | 0.01% | +20.0% |
Q4 2014 | $2,183,000 | +249.3% | 234,442 | +212.6% | 0.01% | +150.0% |
Q3 2014 | $625,000 | -64.0% | 75,000 | -50.0% | 0.00% | -50.0% |
Q2 2014 | $1,734,000 | -50.0% | 150,000 | -45.2% | 0.00% | -55.6% |
Q1 2014 | $3,470,000 | – | 273,661 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |